The emerging role of BET inhibitors in breast cancer

por Andrikopoulou, A., Liontos, M., Koutsoukos, K., Dimopoulos, MA., Zagouri, F.
Publicado 2020

How we treat endocrine complications of immune checkpoint inhibitors

por Paschou, S.A., Stefanaki, K., Psaltopoulou, T., Liontos, M., Koutsoukos, K., Zagouri, F., Lambrinoudaki, I., Dimopoulos, M.-A.
Publicado 2021

Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy

por Liontos, M., Andrikopoulou, A., Koutsoukos, K., Markellos, C., Skafida, E., Fiste, O., Kaparelou, M., Thomakos, N., Haidopoulos, D., Rodolakis, A., Dimopoulos, M. A., Zagouri, F.
Publicado 2021

Axitinib as a third or further line of treatment in renal cancer: a single institution experience

por Tsironis, G., Liontos, M., Kyriazoglou, A., Koutsoukos, K., Tsiara, A., Kaparelou, M., Zakopoulou, R., Cohen, A., Skafida, E., Fontara, S., Zagouri, F., Bamias, A., Dimopoulos, M. A.
Publicado 2020

77P The impact of COVID-19 on gynecological cancer diagnoses in Greece

por Fiste, O., Iliopoulou, P., Tzannis, K., Theofanakis, C., Rouvali, A., Markellos, C., Kunadis, E., Potiri, E., Papanota, A-M., Papatheodoridi, A., Andrikopoulou, A., Svarna, A., Kaparelou, M., Koutsoukos, K., Thomakos, N., Haidopoulos, D., Rodolakis, A., Zagouri, F., Dimopoulos, M., Liontos, M.
Publicado 2023